Status: Not yet recruiting
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
The objectives of this study are to describe the incidence of adverse events and the effectiveness of tezepelumab in patients receiving tezepelumab as indicated for severe asthma or CRSwNP in South Korea.
Participants needed: 210
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: AstraZenecaUpdated: Jun 4, 2026
Eligibility criteria
Patients who are treated with at least one dose of tezepelumab according to the... [+1]
Other off-label indications according to the locally approved prescribing inform... [+1]